Shares of Multi Commodity Exchange of India (MCX) are in the spotlight following a significant revision from global brokerage firm Morgan Stanley. The firm has upgraded its rating on the stock and raised its price target by a substantial 66%, signaling renewed confidence in the commodity exchange's growth trajectory. This move is primarily driven by a remarkable surge in trading activity on the platform, a trend that Morgan Stanley believes has lasting momentum.
Morgan Stanley has shifted its stance on MCX to 'Equalweight' and increased its target price to ₹11,135 from the earlier ₹6,710. This 66% hike, however, suggests a limited upside of about 2% from the stock's closing price of ₹10,942 on the day of the report. The upgrade is a notable development, reflecting a positive reassessment of the company's operational performance and future earnings potential.
The core reason behind the brokerage's optimistic revision is the sharp increase in MCX's average daily transaction revenue (ADTR) over the last three months. This surge is attributed to heightened price volatility and increased trading action across various commodities. Morgan Stanley's report highlights that this momentum does not appear to be fading, suggesting that the higher revenue run-rate could be sustainable for the foreseeable future. Sustained high trading volumes are critical for MCX, as transaction fees form the bulk of its revenue.
Reflecting this positive outlook on revenue, Morgan Stanley has materially raised its earnings estimates for MCX. The brokerage has increased its earnings per share (EPS) forecasts by 15% for the fiscal year 2026 (FY26), 20% for FY27, and a significant 24% for FY28. The report also flags potential for further upside to these estimates if the currently elevated transaction volumes are sustained over the long term, though it acknowledges that these volumes can be volatile.
From a valuation standpoint, MCX currently trades at approximately 50 times its estimated FY27 earnings and 47.5 times its FY28 estimated earnings. Morgan Stanley's analysis suggests that if the average daily transaction revenue stabilizes at ₹104 million through FY27-FY28, the stock would trade at a more attractive multiple of about 35 times earnings. This valuation would represent a 5% premium to its long-term average, indicating that sustained performance could justify its current market price and potentially lead to further re-rating.
MCX has been a strong performer in the market, delivering impressive returns to its investors. The stock has surged by nearly 76% over the past year, showcasing strong market confidence. The broader analyst community holds a mixed but generally positive view on the stock.
This consensus indicates that while many analysts are bullish on the company's prospects, some prefer a cautious approach, likely waiting to see if the high trading volumes persist.
While Morgan Stanley's upgrade is a significant endorsement, it's worth noting the diverse opinions among other brokerage houses. For instance, UBS has also expressed a highly bullish view, recently raising its price target for MCX to ₹12,000. UBS cited strong performance driven by elevated bullion prices, higher volatility, and growing interest in energy commodities as key growth drivers. This contrasts with some earlier, more cautious reports, highlighting the dynamic nature of market analysis for a company so closely tied to market volatility.
Morgan Stanley's 66% target price hike for MCX underscores the exchange's strong recent performance and its potential for sustained earnings growth. The upgrade is firmly rooted in the surge in transaction revenues fueled by commodity market volatility. For investors, the key factor to monitor will be the sustainability of these high trading volumes. While the stock has already seen a significant run-up, continued operational strength and favorable market conditions could support its valuation and future performance. The focus now shifts to whether MCX can maintain this momentum in the coming quarters.